Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Integrating clinical trial findings into practice through risk stratification: the case of heart failure management.

Smith DH, Johnson ES, Thorp ML, Crispell KA, Yang X, Petrik AF.

Popul Health Manag. 2010 Jun;13(3):123-9. doi: 10.1089/pop.2009.0047.

PMID:
20455788
2.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

3.

Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial.

Gregory D, Kimmelstiel C, Perry K, Parikh A, Konstam V, Konstam MA.

Am Heart J. 2006 May;151(5):1013-8.

PMID:
16644325
4.
5.

Metaanalysis and review of heart failure disease management randomized controlled clinical trials.

Whellan DJ, Hasselblad V, Peterson E, O'Connor CM, Schulman KA.

Am Heart J. 2005 Apr;149(4):722-9. Review.

PMID:
15990759
6.

A systematic review of randomized trials of disease management programs in heart failure.

McAlister FA, Lawson FM, Teo KK, Armstrong PW.

Am J Med. 2001 Apr 1;110(5):378-84.

PMID:
11286953
7.

Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration.

Wang L, Porter B, Maynard C, Bryson C, Sun H, Lowy E, McDonell M, Frisbee K, Nielson C, Fihn SD.

Am J Cardiol. 2012 Nov 1;110(9):1342-9. doi: 10.1016/j.amjcard.2012.06.038. Epub 2012 Jul 21.

PMID:
22819429
8.

Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure.

Riegel B, Carlson B, Kopp Z, LePetri B, Glaser D, Unger A.

Arch Intern Med. 2002 Mar 25;162(6):705-12.

PMID:
11911726
9.

Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial.

Kimmelstiel C, Levine D, Perry K, Patel AR, Sadaniantz A, Gorham N, Cunnie M, Duggan L, Cotter L, Shea-Albright P, Poppas A, LaBresh K, Forman D, Brill D, Rand W, Gregory D, Udelson JE, Lorell B, Konstam V, Furlong K, Konstam MA.

Circulation. 2004 Sep 14;110(11):1450-5. Epub 2004 Aug 16.

10.

Care management for low-risk patients with heart failure: a randomized, controlled trial.

DeBusk RF, Miller NH, Parker KM, Bandura A, Kraemer HC, Cher DJ, West JA, Fowler MB, Greenwald G.

Ann Intern Med. 2004 Oct 19;141(8):606-13.

PMID:
15492340
11.

Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.

Capomolla S, Febo O, Ceresa M, Caporotondi A, Guazzotti G, La Rovere M, Ferrari M, Lenta F, Baldin S, Vaccarini C, Gnemmi M, Pinna G, Maestri R, Abelli P, Verdirosi S, Cobelli F.

J Am Coll Cardiol. 2002 Oct 2;40(7):1259-66.

12.

A heart failure self-management program for patients of all literacy levels: a randomized, controlled trial [ISRCTN11535170].

DeWalt DA, Malone RM, Bryant ME, Kosnar MC, Corr KE, Rothman RL, Sueta CA, Pignone MP.

BMC Health Serv Res. 2006 Mar 13;6:30.

13.

Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study.

Ahmed A, Allman RM, Fonarow GC, Love TE, Zannad F, Dell'italia LJ, White M, Gheorghiade M.

J Card Fail. 2008 Apr;14(3):211-8. doi: 10.1016/j.cardfail.2007.12.001.

14.

Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure.

Liu MH, Wang CH, Huang YY, Tung TH, Lee CM, Yang NI, Liu PC, Cherng WJ.

J Cardiovasc Med (Hagerstown). 2012 May;13(5):299-306. doi: 10.2459/JCM.0b013e328351677f.

PMID:
22367574
15.

Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.

Fowler MB, Vera-Llonch M, Oster G, Bristow MR, Cohn JN, Colucci WS, Gilbert EM, Lukas MA, Lacey MJ, Richner R, Young ST, Packer M.

J Am Coll Cardiol. 2001 May;37(6):1692-9.

16.

Improving outcomes in heart failure in the community: long-term survival benefit of a disease-management program.

Akosah KO, Schaper AM, Haus LM, Mathiason MA, Barnhart SI, McHugh VL.

Chest. 2005 Jun;127(6):2042-8.

PMID:
15947318
17.

Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.

Caro JJ, Migliaccio-Walle K, O'Brien JA, Nova W, Kim J, Hauch O, Hillson E, Wedel H, Hjalmarson A, Gottlieb S, Deedwania PC, Wikstrand J; MERIT-HF Study Group.

J Card Fail. 2005 Dec;11(9):647-56.

PMID:
16360958
18.

Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.

Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH.

J Card Fail. 2009 Aug;15(6):475-81. doi: 10.1016/j.cardfail.2009.01.012. Epub 2009 Mar 17.

PMID:
19643357
19.
20.

Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure.

Drazner MH, Rame JE, Stevenson LW, Dries DL.

N Engl J Med. 2001 Aug 23;345(8):574-81.

Supplemental Content

Support Center